Early age at first childbirth associated with advanced tumor grade in breast cancer

https://doi.org/10.1016/j.cdp.2008.04.001Get rights and content

Abstract

Background: Many studies have investigated risk factors for developing breast cancer, but few have explored whether these risk factors are associated with the aggressiveness of the tumor. This case–case study examined the relationship between risk factors for breast cancer and the histological grade of the tumor at diagnosis, an important indicator of breast cancer aggressiveness. Methods: We interviewed 215 breast cancer patients and obtained information on their demographics, reproductive history and hormone use. Grade of tumor was obtained from a review of the patients’ pathological reports. The relationships between tumor aggressiveness (classified by tumor grade) and risk factors of interest were analyzed using multi-variable logistic regression. Maximum likelihood estimates of the odds ratio were obtained and 95% confidence intervals (CI) were calculated. Results: In multivariable analyses we found that when comparing women who had their first child before age 20 with those who had their first child age 20 and older, women who had their first child before age 20 had approximately a 3.2 increased odds of having a higher-grade tumor (OR = 3.20; 95% CI = 1.20, 8.49). Long-term use of oral contraceptives, measured in years of oral contraceptive use, was also positively associated with a higher-grade tumor (OR = 1.12; 95% CI = 1.03–1.23). In addition we found that younger age at diagnosis was a strong predictor of a higher-grade tumor, with a 4% increased odds of having a higher-grade tumor for each year younger (OR = 0.96; 95% CI = 0.93–0.995). Conclusions: Early age at first birth, long-term use of oral contraceptives, and younger age at diagnosis were associated with advanced tumor grade.

Introduction

Many studies have investigated risk factors for developing breast cancer, and some studies have investigated the influence of these risk factors on survival. However, very few studies have explored whether these risk factors are associated with the aggressiveness of the tumor, an important determinant of survival. The purpose of this study was to examine the relationships between these risk factors and histological tumor grade at time of diagnosis, an indicator of tumor aggressiveness. We chose tumor grade because many studies have shown that tumor grade is a statistically significant prognostic factor for disease free survival and overall survival in breast cancer [1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], and because tumor grade is determined at the time of diagnosis and is not influenced by treatment.

Section snippets

Study design

The case–case design was used to examine the relationship between risk factors for developing breast cancer and the histological grade of the tumor at presentation. IRB approval was obtained for this study.

Study population

All female breast cancer patients seen at The George Washington University Medical Faculty Associates (GWUMFA) Hematology/Oncology Center from September 1995 to December 1996 who had an infiltrating ductal or lobular breast tumor were candidates for this study. Their physicians recruited the

Results

A total of 215 breast cancer patients were included in this study. 116 (54%) had aggressive tumors and 99 (46%) had non-aggressive tumors (classified by tumor grade). There were 135 (63%) Caucasians, 67 (31%) African-Americans, and 13 (6%) of other races in the study. One hundred fifty-four (72%) of the patients in the study reported at least one live birth. Of the women who had children, 34 (22%) of them had their first child before the age of 20. Of the patients who had their first child

Discussion

Our data indicate that the most important factors associated with aggressiveness were early age at first birth, “never users” of OCs, long-term use of OCs, and younger age at diagnosis.

Conclusion

This pilot study found that the age when a woman had her first child, her OC use, and her age at diagnosis were associated with the aggressiveness of the tumor, as measured by tumor grade. Exposure to hormones are involved in these three factors. Younger women have higher levels of endogenous hormones. Long-term use of oral contraceptives exposes the woman to exogenous hormones on a continual basis. A woman is exposed to high levels of endogenous hormones during pregnancy. These exposures and

Conflict of interest statement

None declared.

References (65)

  • H. Bloom

    Prognosis in carcinoma of the breast

    Br J Cancer

    (1950)
  • H. Bloom et al.

    Histological grading and prognosis in breast cancer

    Br J Cancer

    (1957)
  • E.R. Fisher et al.

    Pathologic findings from the National Surgical Adjuvant Breast and Bowel Projects (NSABP). Prognostic discriminants for 8-year survival for node-negative invasive breast cancer patients

    Cancer

    (1990)
  • B.W. Davis et al.

    Prognostic significance of tumor grade in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis

    Cancer

    (1986)
  • S.E. Pinder et al.

    The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy

    Cancer

    (1998)
  • R. Seshadri et al.

    A simple index to predict prognosis independent of axillary node information in breast cancer

    Aust N Z J Surg

    (1997)
  • M.T. Carriaga et al.

    The histologic grading of cancer

    Cancer

    (1995)
  • L.S. Freedman et al.

    Histological grade and other prognostic factors in relation to survival of patients with breast cancer

    Br J Cancer

    (1979)
  • M.H. Galea et al.

    The Nottingham Prognostic Index in primary breast cancer

    Breast Cancer Res Treat

    (1992)
  • C.W. Elston et al.

    Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

    Histopathology

    (1991)
  • M. Saimura et al.

    Prognosis of a series of 763 consecutive node-negative invasive breast cancer patients without adjuvant therapy: analysis of clinicopathological prognostic factor

    J Surg Oncol

    (1999)
  • H. Okugawa et al.

    Prognostic factors in breast cancer: the value of the Nottingham Prognostic Index for patients treated in a single institution

    Surg Today

    (2005)
  • J. Rosenberg et al.

    The effect of age, race, tumor size, tumor grade, and disease stage on invasive ductal breast cancer survival in the U.S. SEER database

    Breast Cancer Res Treat

    (2005)
  • B.B. Gerstman et al.

    Trends in the content and use of oral contraceptives in the United States, 1964–1988

    Am J Public Health

    (1991)
  • Oral contraceptives and breast cancer. Washington, DC: National Academy Press;...
  • W.C. Chie et al.

    Age at any full-term pregnancy and breast cancer risk

    Am J Epidemiol

    (2000)
  • J.A. Largent et al.

    Effect of reproductive factors on stage, grade and hormone receptor status in early-onset breast cancer

    Breast Cancer Res

    (2005)
  • L.J. Schouten et al.

    Prognostic significance of etiological risk factors in early breast cancer

    Breast Cancer Res Treat

    (1997)
  • N. Kroman et al.

    Parity age at first childbirth and the prognosis of primary breast cancer

    Br J Cancer

    (1998)
  • E.R. Greenberg et al.

    Body size and survival in premenopausal breast cancer

    Br J Cancer

    (1985)
  • K.F. Trivers et al.

    Association between reproductive factors and breast cancer survival in younger women

    Breast Cancer Res Treat

    (2007)
  • S. Chang et al.

    Inflammatory breast cancer and body mass index

    J Clin Oncol

    (1998)
  • Cited by (13)

    • Clinicopathologic Factors Related to the Histological Tumor Grade of Breast Cancer in Western China: An Epidemiological Multicenter Study of 8619 Female Patients

      2018, Translational Oncology
      Citation Excerpt :

      Moreover, it is generally acknowledged that a higher tumor grade is directly related to poorer prognosis of breast cancer patients [7]. Previous studies have shown that pathologic factors, such as human epidermal growth factor receptor 2 (HER-2), estrogen receptor (PR), and progesterone receptor (PR), may be related to the tumor grade of breast carcinomas [8,9]. A higher tumor grade leads to more aggressive breast carcinomas and poor survival, likely due to hormone receptor negativity, HER-2 positivity, and a larger tumor size of breast carcinomas [10,11].

    • Consensus on Breast Cancer and Fertility

      2015, Revista de Senologia y Patologia Mamaria
    View all citing articles on Scopus

    Sources of support: Supported by Susan G. Komen Foundation, grant # BCTR0000510.

    View full text